Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (541-550 of 633) with videos related to

Pageof 64
Sort By:
Journal of Medicinal Chemistry|March 30, 2023
Discovery of a Novel, Potent, Orally Active, and Safe Inhibitor Targeting Human Mitochondrial RNA PolymeraseXinnan Li, Xiaotong Ze, Shengnan Zhou, et al.
Journal of Medicinal Chemistry|April 25, 2020
Discovery of Potent Inhibitors against P-Glycoprotein-Mediated Multidrug Resistance Aided by Late-Stage Functionalization of a 2-(4-(Pyridin-2-yl)phenoxy)pyridine AnalogueYao Ma, Dawei Yin, Jingjia Ye, et al.
Arthritis Care & Research|August 4, 2025
Global and regional temporal changes in cross-country inequalities of site-specific osteoarthritis burden, 1990-2021Haowei Chen, Lei Si, David J Hunter, et al.
Journal of Medicinal Chemistry|December 7, 2020
Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-<i>a</i>]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 ModulatorsShuai Wang, Sai-Qi Wang, Qiu-Xu Teng, et al.
Journal of Cellular Biochemistry|November 22, 2015
Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-κB Pathway in Colorectal CancerHua Sui, Li-Hong Zhou, Ya-Li Zhang, et al.
BMJ Open|November 28, 2025
Association between periprocedural change in serum renalase and microvascular obstruction in patients with STEMI after primary percutaneous coronary intervention: protocol for the ReMVOS prospective cohort studyYe Chen, Ruixuan Li, Ru Fu, et al.
Cancer Research|November 17, 2007
Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistanceZhi Shi, Xing-Xiang Peng, In-Wha Kim, et al.
Plos One|October 12, 2012
High expression of GOLPH3 in esophageal squamous cell carcinoma correlates with poor prognosisJian-Hua Wang, Xiu-Ting Chen, Zhe-Sheng Wen, et al.
Cancer Letters|March 9, 2018
Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivoGuan-Nan Zhang, Yun-Kai Zhang, Yi-Jun Wang, et al.
Plos One|January 26, 2013
BIRB796, the inhibitor of p38 mitogen-activated protein kinase, enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cellsDan He, Xiao-qin Zhao, Xing-gui Chen, et al.
Pageof 64

Showing results (541-550 of 633) with videos related to

Sort By:
Pageof 64
Journal of Medicinal Chemistry|March 30, 2023
Discovery of a Novel, Potent, Orally Active, and Safe Inhibitor Targeting Human Mitochondrial RNA PolymeraseXinnan Li, Xiaotong Ze, Shengnan Zhou, et al.
Journal of Medicinal Chemistry|April 25, 2020
Discovery of Potent Inhibitors against P-Glycoprotein-Mediated Multidrug Resistance Aided by Late-Stage Functionalization of a 2-(4-(Pyridin-2-yl)phenoxy)pyridine AnalogueYao Ma, Dawei Yin, Jingjia Ye, et al.
Arthritis Care & Research|August 4, 2025
Global and regional temporal changes in cross-country inequalities of site-specific osteoarthritis burden, 1990-2021Haowei Chen, Lei Si, David J Hunter, et al.
Journal of Medicinal Chemistry|December 7, 2020
Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-<i>a</i>]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 ModulatorsShuai Wang, Sai-Qi Wang, Qiu-Xu Teng, et al.
Journal of Cellular Biochemistry|November 22, 2015
Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-κB Pathway in Colorectal CancerHua Sui, Li-Hong Zhou, Ya-Li Zhang, et al.
BMJ Open|November 28, 2025
Association between periprocedural change in serum renalase and microvascular obstruction in patients with STEMI after primary percutaneous coronary intervention: protocol for the ReMVOS prospective cohort studyYe Chen, Ruixuan Li, Ru Fu, et al.
Cancer Research|November 17, 2007
Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistanceZhi Shi, Xing-Xiang Peng, In-Wha Kim, et al.
Plos One|October 12, 2012
High expression of GOLPH3 in esophageal squamous cell carcinoma correlates with poor prognosisJian-Hua Wang, Xiu-Ting Chen, Zhe-Sheng Wen, et al.
Cancer Letters|March 9, 2018
Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivoGuan-Nan Zhang, Yun-Kai Zhang, Yi-Jun Wang, et al.
Plos One|January 26, 2013
BIRB796, the inhibitor of p38 mitogen-activated protein kinase, enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cellsDan He, Xiao-qin Zhao, Xing-gui Chen, et al.
Pageof 64